Klaus Medenbach, MD | |
1107 14th Ave Se, Suite G200, Decatur, AL 35601-3309 | |
(256) 353-0605 | |
(256) 353-0618 |
Full Name | Klaus Medenbach |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1107 14th Ave Se, Decatur, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659582658 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 8696 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Klaus Medenbach, MD 1107 14th Ave Se, Suite G200, Decatur, AL 35601-3309 Ph: (256) 353-0605 | Klaus Medenbach, MD 1107 14th Ave Se, Suite G200, Decatur, AL 35601-3309 Ph: (256) 353-0605 |
News Archive
Sonomax Hearing Healthcare Inc. is pleased to announce that its shareholders and noteholders approved a previously-announced Arrangement with Benvest New Look Income Fund at a special meeting of Sonomax security holders held today in Montreal.
The U.S. Department of Health and Human Services (HHS) today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.
In newly updated clinical guidelines from the Society for Integrative Oncology, researchers at Columbia University's Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with an interdisciplinary team of colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering Cancer Center, and other institutions in the U.S. and Canada, analyzed which integrative treatments are most effective and safe for patients with breast cancer.
Children of obese parents may be at risk for developmental delays, according to a study by researchers at the National Institutes of Health.
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.
› Verified 7 days ago
William E Hughes, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1210 14th Ave Se, Suite G200, Decatur, AL 35601 Phone: 256-353-0605 Fax: 256-353-0618 | |
Dr. Sergey Ananyev, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1210 14th Ave Se, Decatur, AL 35601 Phone: 256-353-0605 | |
Dr. Samuel Britt Owens, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2320 Brookwood Dr Se, Decatur, AL 35601 Phone: 256-355-2493 |